MARKET TALK: FDA Servers Down, Review Of Brilinta Delayed

26th Jul 2010 17:19

12:19 (Dow Jones) The posting of FDA's review of AstraZeneca's (AZN) proposed anticlotting drug Brilinta has been delayed because some of FDA's servers are down. The agency lost electricity yesterday after severe storms cut power to much of Montgomery County Maryland, where FDA is located. AZN off a fraction at $48.48. ([email protected]) Call us at (212) 416-2180 or email [email protected] Visit the Market Talk blog at www.djnmarkettalk.com (END) Dow Jones Newswires July 26, 2010 12:19 ET (16:19 GMT)